000 | 01305 a2200361 4500 | ||
---|---|---|---|
005 | 20250515232340.0 | ||
264 | 0 | _c20101216 | |
008 | 201012s 0 0 eng d | ||
022 | _a1563-258X | ||
024 | 7 |
_a10.1007/s10354-010-0793-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWolf, Jeanette | |
245 | 0 | 0 |
_aAnkylosing spondylitis. _h[electronic resource] |
260 |
_bWiener medizinische Wochenschrift (1946) _cMay 2010 |
||
300 |
_a211-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
650 | 0 | 4 |
_aBiological Products _xtherapeutic use |
650 | 0 | 4 | _aBlood Sedimentation |
650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aDiagnostic Imaging |
650 | 0 | 4 | _aExercise |
650 | 0 | 4 |
_aHLA-B27 Antigen _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aRheumatoid Factor _xblood |
650 | 0 | 4 |
_aSacroiliitis _xdiagnosis |
650 | 0 | 4 |
_aSpondylitis, Ankylosing _xdiagnosis |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aFasching, Peter | |
773 | 0 |
_tWiener medizinische Wochenschrift (1946) _gvol. 160 _gno. 9-10 _gp. 211-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10354-010-0793-2 _zAvailable from publisher's website |
999 |
_c19974864 _d19974864 |